Shockwave Medical(@ShockwaveIVL):Momentum continues for the SKYWARD IDE clinical program with the first SKYWARD Transfemoral (TF) enrollment! ⚡ Huge congratulations to Dr. Peter Soukas and the team at The Miriam Hospital on enrolling the first transfemoral access patient in SKYWARD, the clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This milestone marks another important step forward as we continue to advance innovation in the treatment of calcified carotid disease. CAUTION - Investigational device. Limited by U.S. law to investigational use.

2026.09.10 18:01

Momentum continues for the SKYWARD IDE clinical program with the first SKYWARD Transfemoral (TF) enrollment! ⚡ Huge congratulations to Dr. Peter Soukas and the team at The Miriam Hospital on enrolling the first transfemoral access patient in SKYWARD, the clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This milestone marks another important step forward as we continue to advance innovation in the treatment of calcified carotid disease. CAUTION - Investigational device. Limited by U.S. law to investigational use.